CD274 and non-small cell lung carcinoma: In accordance with the 2018 NCCN Clinical Practice Guidelines for Non-Small Cell Lung Cancer (NSCLC) (14), treatment stratification for advanced NSCLC patients at initial diagnosis should include both genetic testing and PD-L1 expression analysis.